Nontuberculous mycobacteria isolated from specimens of pulmonary tuberculosis suspects, Northern Tunisia: 2002-2016.
Adult
Bronchoalveolar Lavage Fluid
/ microbiology
Female
Humans
Male
Mycobacterium Infections, Nontuberculous
/ diagnosis
Nontuberculous Mycobacteria
/ classification
Phylogeny
Prevalence
RNA, Ribosomal, 16S
/ chemistry
Retrospective Studies
Sputum
/ microbiology
Tuberculosis, Pulmonary
/ diagnosis
Tunisia
/ epidemiology
Nontuberculous mycobacteria
Phylogeny
Pulmonary NTM
Pulmonary disease; molecular identification
Tunisia
Journal
BMC infectious diseases
ISSN: 1471-2334
Titre abrégé: BMC Infect Dis
Pays: England
ID NLM: 100968551
Informations de publication
Date de publication:
18 Sep 2019
18 Sep 2019
Historique:
received:
21
05
2019
accepted:
04
09
2019
entrez:
20
9
2019
pubmed:
20
9
2019
medline:
27
11
2019
Statut:
epublish
Résumé
Reports on the worldwide ascending trend of pulmonary nontuberculous mycobacteria (NTM) isolation rates and their effective role in respiratory tract infections are compelling. However, as yet, there are no such data relating to Tunisia. Here we carried out a retrospective review of mycobacterial cultures originating from Northern Tunisia, which have been processed in the laboratory of mycobacteria of the Institut Pasteur de Tunis, during the time period 2002-2016. All pulmonary NTM (PNTM) isolates available for culture were characterized phenotypically and their taxonomic status was further established based on polymorphisms in rpoB, 16S rRNA, hsp65, and sodA DNA gene sequences. Of the 10,466 specimens collected from HIV-negative Tunisian patients with presumptive clinical pulmonary TB, 60 (0.6%) yielded PNTM isolates. An overall annual PNTM isolation prevalence of 0.2/100,000 was estimated. As far as could be ascertained, this isolation rate accounts amongst the lowest reported hitherto throughout the world. Among the 30 NTM isolates that were available for culture, 27 (90.0%) have been identified to the species level. The most commonly encountered species was Mycobacterium kansasii (23.3%) subtype 1. Strikingly, all M. kansasii cases were male patients originating from Bizerte, an industrialized region particularly known for iron industry. The remaining NTM species were M. fortuitum (16.6%), M. novocastrense (16.6%), M. chelonae (10.0%), M. gordonae (6.6%), M. gadium (6.6%), M. peregrinum (3.3%), M. porcinum (3.3%), and M. flavescens (3.3%). There were no bacteria of the M. avium complex, the most frequently isolated NTM globally, and the main driver of the rise of NTM-lung diseases. This study uncovered an exceptional low prevalence of PNTM isolation among HIV-negative TB suspects in Northern Tunisia, suggesting a very low burden of NTM pulmonary disease. However, the frequent isolation of M. kansasii subtype 1, the most pathogenic subtype, particularly from the industrialized region of Bizerte, strongly suggests its effective involvement in a typical pulmonary disease.
Sections du résumé
BACKGROUND
BACKGROUND
Reports on the worldwide ascending trend of pulmonary nontuberculous mycobacteria (NTM) isolation rates and their effective role in respiratory tract infections are compelling. However, as yet, there are no such data relating to Tunisia.
METHODS
METHODS
Here we carried out a retrospective review of mycobacterial cultures originating from Northern Tunisia, which have been processed in the laboratory of mycobacteria of the Institut Pasteur de Tunis, during the time period 2002-2016. All pulmonary NTM (PNTM) isolates available for culture were characterized phenotypically and their taxonomic status was further established based on polymorphisms in rpoB, 16S rRNA, hsp65, and sodA DNA gene sequences.
RESULTS
RESULTS
Of the 10,466 specimens collected from HIV-negative Tunisian patients with presumptive clinical pulmonary TB, 60 (0.6%) yielded PNTM isolates. An overall annual PNTM isolation prevalence of 0.2/100,000 was estimated. As far as could be ascertained, this isolation rate accounts amongst the lowest reported hitherto throughout the world. Among the 30 NTM isolates that were available for culture, 27 (90.0%) have been identified to the species level. The most commonly encountered species was Mycobacterium kansasii (23.3%) subtype 1. Strikingly, all M. kansasii cases were male patients originating from Bizerte, an industrialized region particularly known for iron industry. The remaining NTM species were M. fortuitum (16.6%), M. novocastrense (16.6%), M. chelonae (10.0%), M. gordonae (6.6%), M. gadium (6.6%), M. peregrinum (3.3%), M. porcinum (3.3%), and M. flavescens (3.3%). There were no bacteria of the M. avium complex, the most frequently isolated NTM globally, and the main driver of the rise of NTM-lung diseases.
CONCLUSIONS
CONCLUSIONS
This study uncovered an exceptional low prevalence of PNTM isolation among HIV-negative TB suspects in Northern Tunisia, suggesting a very low burden of NTM pulmonary disease. However, the frequent isolation of M. kansasii subtype 1, the most pathogenic subtype, particularly from the industrialized region of Bizerte, strongly suggests its effective involvement in a typical pulmonary disease.
Identifiants
pubmed: 31533664
doi: 10.1186/s12879-019-4441-1
pii: 10.1186/s12879-019-4441-1
pmc: PMC6751674
doi:
Substances chimiques
RNA, Ribosomal, 16S
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
819Subventions
Organisme : Tunisian Ministry of Higher Education and Scientific Research
ID : LR16IPT01
Références
J Clin Microbiol. 2002 Mar;40(3):943-50
pubmed: 11880421
Clin Chest Med. 2002 Sep;23(3):613-21, vi
pubmed: 12370997
J Clin Microbiol. 2003 Mar;41(3):1240-4
pubmed: 12624057
Antonie Van Leeuwenhoek. 2003;83(3):265-74
pubmed: 12776922
Eur Respir J. 2004 May;23(5):741-6
pubmed: 15176690
Chest. 2004 Aug;126(2):566-81
pubmed: 15302746
Infection. 2004 Oct;32(5):257-70
pubmed: 15624889
Thorax. 2007 Aug;62(8):661-6
pubmed: 17311842
Int J Tuberc Lung Dis. 2008 Jul;12(7):807-12
pubmed: 18544208
Arch Pathol Lab Med. 2008 Aug;132(8):1333-41
pubmed: 18684037
J Bras Pneumol. 2008 Nov;34(11):950-5
pubmed: 19099102
Thorax. 2009 Jun;64(6):502-6
pubmed: 19213773
Clin Infect Dis. 2009 Dec 15;49(12):e124-9
pubmed: 19911942
Am J Respir Crit Care Med. 2010 Mar 1;181(5):514-21
pubmed: 20007929
Scand J Infect Dis. 2010 Aug;42(8):626-8
pubmed: 20632900
Can Respir J. 2011 Jan-Feb;18(1):19-24
pubmed: 21369546
Eur Respir J. 2013 Dec;42(6):1604-13
pubmed: 23598956
Int J Tuberc Lung Dis. 2013 Jun;17(6):836-41
pubmed: 23676172
Mem Inst Oswaldo Cruz. 2013 Jun;108(4):457-62
pubmed: 23827995
Emerg Infect Dis. 2013 Nov;19(11):1889-91
pubmed: 24210012
J Clin Microbiol. 2014 Jul;52(7):2544-51
pubmed: 24808238
PLoS One. 2014 Oct 16;9(10):e109736
pubmed: 25330201
PLoS One. 2014 Dec 08;9(12):e114428
pubmed: 25485795
Clin Chest Med. 2015 Mar;36(1):1-11
pubmed: 25676515
Clin Chest Med. 2015 Mar;36(1):13-34
pubmed: 25676516
Biomed Res Int. 2015;2015:959107
pubmed: 26180817
Int J Infect Dis. 2016 Mar;44:66-73
pubmed: 26948920
Mol Biol Evol. 2016 Jul;33(7):1870-4
pubmed: 27004904
J Clin Microbiol. 2017 May;55(5):1469-1477
pubmed: 28228494
Sci Rep. 2017 Sep 20;7(1):12002
pubmed: 28931915
J Infect Dis. 2018 Jul 24;218(5):679-687
pubmed: 29635431
Front Microbiol. 2018 Aug 30;9:2029
pubmed: 30214436
J Clin Microbiol. 2019 Jan 30;57(2):
pubmed: 30487305
Am Rev Respir Dis. 1987 May;135(5):1007-14
pubmed: 3579001
J Clin Microbiol. 1993 Feb;31(2):175-8
pubmed: 8381805
Ann Intern Med. 1998 Nov 1;129(9):698-704
pubmed: 9841601